[Selegiline in the therapy of Parkinson's disease].
Stojiljković
M P
MP
Medicinsko odeljenje, Vojnotehnicki institut, Beograd.
Dragojević-Simić
V
V
Bosković
B
B
D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D012642:Selegiline / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*
D012642:Selegiline
Selegilin u terapiji Parkinsonove bolesti.